The impact of harboring the rs72963007 TET2 allele or a TET2 somatic mutation on genomic hydroxymethylation and TET2 expression in ATLL tumor T cells was next studied. The gene discussed is TET2; the disease is adult T-cell leukemia/lymphoma.